Search
C4 Therapeutics Inc
CCCCAdd to Watchlist
4.300USD
-0.040-0.92%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
318.95MMarket Cap
LossP/E TTM
C4 Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of C4 Therapeutics Inc is 7.29, ranking 245 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.93, which is -89.08% below the recent high of -0.43 and -8.60% above the recent low of -4.27.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.